Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1968 1
1971 1
1974 2
1976 1
1978 2
1981 1
1982 1
1988 1
1991 1
1995 1
1996 2
1997 3
2004 1
2005 2
2006 3
2007 4
2008 5
2009 1
2011 1
2012 1
2014 4
2015 3
2016 2
2017 3
2018 2
2019 1
2021 5
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis.
Siltari A, Lönnerbro R, Pang K, Shiranov K, Asiimwe A, Evans-Axelsson S, Franks B, Kiran A, Murtola TJ, Schalken J, Steinbeisser C, Bjartell A, Auvinen A; PIONEER Consortium. Siltari A, et al. Clin Genitourin Cancer. 2023 Apr;21(2):316.e1-316.e11. doi: 10.1016/j.clgc.2022.09.006. Epub 2022 Sep 11. Clin Genitourin Cancer. 2023. PMID: 36243664 Free article. Review.
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol.
Beyer K, Moris L, Lardas M, Haire A, Barletta F, Scuderi S, Vradi E, Gandaglia G, Omar MI, MacLennan S, Zong J, Farahmand B, Maclennan SJ, Devecseri Z, Asiimwe A, Collette L, Bjartell A, Ndow J, Briganti A, Van Hemelrijck M; PIONEER Consortium. Beyer K, et al. BMJ Open. 2021 Feb 11;11(2):e040531. doi: 10.1136/bmjopen-2020-040531. BMJ Open. 2021. PMID: 33574142 Free PMC article.
Author response to 'Comment on "Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer" (Ther Adv Med Oncol. 2021 Sep 30;13:17588359211049639)'.
Hettle R, McCrea C. Hettle R, et al. Among authors: mccrea c. Ther Adv Med Oncol. 2023 Apr 17;15:17588359231168519. doi: 10.1177/17588359231168519. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37113736 Free PMC article. No abstract available.
Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Evans R, Hawkins N, Dequen-O'Byrne P, McCrea C, Muston D, Gresty C, Ghate SR, Fan L, Hettle R, Abrams KR, de Bono J, Hussain M, Agarwal N. Evans R, et al. Among authors: mccrea c. Target Oncol. 2021 Sep;16(5):613-623. doi: 10.1007/s11523-021-00837-y. Epub 2021 Sep 3. Target Oncol. 2021. PMID: 34478046 Free PMC article.
57 results